Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
This study has been completed.
Study NCT00057512 Information provided by Erimos Pharmaceuticals
First Received: April 3, 2003 Last Updated: January 31, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Neoplasms
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Neoplasms by Site
Additional drug interventions recognized in this trial
Nordihydroguaiaretic Acid
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antioxidants
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Lipoxygenase Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Erimos Pharmaceuticals
Duke University
Medical University of South Carolina
Back to top of Main Content
